American Samoa vs Iraq: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
American Samoa
0.4%
in 2024
Iraq
0.4%
in 2024
American Samoa rank
59th
Iraq rank
59th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- American Samoa
- Iraq
How they compare
American Samoa currently reports 0.4% against 0.4% in Iraq, a difference of 0.0%.
Across all 10 years both countries report, Iraq has been ahead every year.
American Samoa ranks 59th and Iraq ranks 59th of 215 countries.
Iraq has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | American Samoa | Iraq | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.4% | 0.8% | 0.3% | Iraq |
| 2020s | 0.5% | 0.5% | 0.1% | Iraq |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, American Samoa or Iraq?
- American Samoa, at 0.4% against 0.4% in Iraq as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between American Samoa and Iraq?
- 0.0%, with American Samoa ahead.
- How many years of comparable data are there for American Samoa and Iraq?
- 10 years are reported by both, from 2015 to 2024.
- How do American Samoa and Iraq rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- American Samoa ranks 59th and Iraq ranks 59th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.